Edman U, Meraz M A, Rausser S, Agabian N, Meza I
Intercampus Program for Molecular Parasitology, University of California, Berkeley.
J Exp Med. 1990 Sep 1;172(3):879-88. doi: 10.1084/jem.172.3.879.
A 125-kD surface antigen of Entamoeba histolytica is recognized by 73% of immune sera from patients with amoebic liver abscesses. Using pooled human immune sera a cDNA clone (lambda cM17) encoding this antigen (M17) has been isolated from a lambda gt11 expression library of the virulent stain E. histolytica HM1:IMSS. Monospecific antibodies, purified by binding to phage lysate of lambda cM17, and mAb FA7 reacted exclusively with the 125-kD antigen by Western blot analysis. Surface binding and cap formation are observed with patient sera, purified monospecific antiserum, and mAb FA7. Corresponding genomic clones (pBSgM17-1/2/3) were isolated by hybridization with the cDNA clone. These contained an open-reading frame of 3345 bp, which is in good agreement with the mRNA size of approximately 3.0 kb as revealed by Northern hybridization with lambda cM17. The inferred amino acid sequence predicts a 125,513 dalton protein that contains 17 potential N-linked glycosylation sites and is unusually rich in tyrosine and asparagine residues. A distinctly hydrophobic NH2-terminal region may serve as membrane anchor or signal sequence. In contrast to conservation of an immunodominant epitope recognized in pathogenic and nonpathogenic strains by monoclonal FA7 and human immune sera, amplification and sequence analysis of a 1,4000-bp fragment of this gene from a fresh nonpathogenic isolate by use of the PCR demonstrate regions of significant sequence divergence in this antigen. A 1% sequence variability among different isolates of the pathogenic strain HM1:IMSS and a 12-13% variability between pathogenic and nonpathogenic strains are revealed by comparison to published partial amino acid sequences (Tannich, E., R.D. Horstmann, J. Knobloch, and H.H. Arnold. 1989. Proc. Natl. Acad. Sci. USA. 86:5118). Some restriction enzymes were found that allowed PCR diagnosis of nonpathogenic and pathogenic isolates with the exclusion of E. histolytica-like Laredo, suggesting that a detailed study of nonpathogenic and pathogenic isolates in relation to the M17 antigen sequence will provide a basis of differentiating isolates.
73%的阿米巴肝脓肿患者的免疫血清可识别溶组织内阿米巴的一种125-kD表面抗原。利用人免疫血清池,从强毒株溶组织内阿米巴HM1:IMSS的λgt11表达文库中分离出一个编码该抗原(M17)的cDNA克隆(λcM17)。通过与λcM17的噬菌体裂解物结合纯化的单特异性抗体和单克隆抗体FA7,经蛋白质印迹分析仅与125-kD抗原发生反应。用患者血清、纯化的单特异性抗血清和单克隆抗体FA7观察到表面结合和帽形成。通过与cDNA克隆杂交分离出相应的基因组克隆(pBSgM17-1/2/3)。这些克隆包含一个3345 bp的开放阅读框,这与用λcM17进行Northern杂交所揭示的约3.0 kb的mRNA大小高度一致。推测的氨基酸序列预测为一种125,513道尔顿的蛋白质,其含有17个潜在的N-连接糖基化位点,并且酪氨酸和天冬酰胺残基异常丰富。一个明显疏水的NH2-末端区域可能作为膜锚定或信号序列。与单克隆抗体FA7和人免疫血清在致病和非致病菌株中识别的免疫显性表位的保守性相反,通过PCR对来自新鲜非致病分离株的该基因的14000-bp片段进行扩增和序列分析,显示该抗原存在明显的序列差异区域。与已发表的部分氨基酸序列(坦尼希,E.,R.D.霍斯特曼,J.诺布洛赫,和H.H.阿诺德。1989.美国国家科学院院刊。86:5118)比较,致病菌株HM1:IMSS的不同分离株之间有1%的序列变异性,致病和非致病菌株之间有12 - 13%的变异性。发现了一些限制酶,可用于非致病和致病分离株的PCR诊断,排除了类似溶组织内阿米巴的拉雷多菌,这表明对与M17抗原序列相关的非致病和致病分离株进行详细研究将为区分分离株提供基础。